Sterling Capital Management’s AtriCure ATRC Stock Holding History

Sterling Capital Management’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.9K	Sell	175 -139	-44%	-$3.91K	﹤0.01%	2627
2026 Q1	$8.96K	Sell	314 -2	-0.6%	-$68	﹤0.01%	2432
2025 Q4	$12.5K	Buy	316 +199	+170%	+$7.29K	﹤0.01%	2495
2025 Q3	$4.12K	Hold	117	–	–	﹤0.01%	2816
2025 Q2	$3.83K	Sell	117 -199	-63%	-$6.47K	﹤0.01%	2654
2025 Q1	$10.2K	Sell	316 -245	-44%	-$9.1K	﹤0.01%	1852
2024 Q4	$17.1K	Buy	561 +469	+510%	+$15.1K	﹤0.01%	1922
2024 Q3	$2.58K	Buy	+92	New	+$2.27K	﹤0.01%	2067

Other funds holding ATRC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Sterling Capital Management's ATRC Position: Q2 2026 in Review

Sterling Capital Management reduced its AtriCure (ATRC) stake by 44% in Q2 2026, selling an estimated $3.91K and leaving 175 shares worth $4.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2627.

Sterling Capital Management first reported a position in ATRC in Q3 2024 and has held it in 8 quarters since. The position peaked at $17.1K in Q4 2024. 252 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.

Sterling Capital Management held 175 shares of AtriCure worth $4.9K as of Q2 2026.
Sterling Capital Management sold 139 AtriCure shares in Q2 2026, an estimated $3.91K.
AtriCure made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #2627 holding.
Sterling Capital Management first reported a position in AtriCure in Q3 2024 and has held it in 8 quarters since.
Sterling Capital Management's AtriCure position peaked at $17.1K in Q4 2024.
252 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.